Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Clinical trial NCT07102628 · RECRUITING
Trial details
- NCT number
- NCT07102628
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-03
- Primary completion
- 2027-02-11
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.